Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 141, Issue 3
April 2019
Acta Haematologica Cover Image for Volume 141, Issue 3
All Issues
ISSN 0001-5792
EISSN 1421-9662

Acta Haematologica 2019, Vol. 141, No. 3

Case Report

Case Report: Development of Factor VIII Inhibitor in a Patient with an Uncommon de novo Mutation in the Factor VIII Gene
Subject Area: Hematology , Oncology
Kirk D. Wyatt; Lea M. Coon; Dawn N. Rusk; Vilmarie Rodriguez; Deepti M. Warad
Acta Haematol (2019) 141 (3): 129–134. https://doi.org/10.1159/000495559
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Letter to the Editor

Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia
Subject Area: Hematology , Oncology
Kenichi Tahara; Hiromi Koiso; Yo-hei Osaki; Tomomi Sekigami; Akihiko Yokohama; Takayuki Saitoh; Norifumi Tsukamoto; Hirokazu Murakami; Masahiro Abe; Hiroshi Handa
Acta Haematol (2019) 141 (3): 135–137. https://doi.org/10.1159/000495741
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Interdisciplinary Perspectives in Hematology

Primary CNS Lymphoma in the Elderly: The Challenge
Subject Area: Hematology , Oncology
Tali Siegal; Osnat Bairey
Acta Haematol (2019) 141 (3): 138–145. https://doi.org/10.1159/000495284
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Letter to the Editor

Replacement Therapy with Glu-Plasminogen for the Treatment of Severe Respiratory and Auditory Complications of Congenital Plasminogen Deficiency
Subject Area: Hematology , Oncology
Klaus Tenbrock; Sylvia Lehmann; Simone Schrading; John Moran
Acta Haematol (2019) 141 (3): 146–147. https://doi.org/10.1159/000495336
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases
Subject Area: Hematology , Oncology
Fanfan Li; Kuangyi Shu; Jie Liu; Chenfang Shen; Xiaoou Wang; Zhaohua Zhang; Minghua Jiang
Acta Haematol (2019) 141 (3): 148–150. https://doi.org/10.1159/000496080
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Review

Inhibitors: A Need for Eradication?
Subject Area: Hematology , Oncology
Elena Santagostino; Guy Young; Carmen Escuriola Ettingshausen; Victor Jimenez-Yuste; Manuel Carcao
Acta Haematol (2019) 141 (3): 151–155. https://doi.org/10.1159/000495454
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Editorial Comment

Time to Understand More about Spontaneous Regression of Cancer
Subject Area: Hematology , Oncology
Tamar Tadmor
Acta Haematol (2019) 141 (3): 156–157. https://doi.org/10.1159/000496680
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Case Report

TAFRO Syndrome with an Anterior Mediastinal Mass and Lethal Autoantibody-Mediated Thrombocytopenia: An Autopsy Case Report
Subject Area: Hematology , Oncology
Kaoru Morita; Shin-ichiro Fujiwara; Takashi Ikeda; Shin-ichiro Kawaguchi; Yumiko Toda; Shoko Ito; Shin-ichi Ochi; Takashi Nagayama; Kiyomi Mashima; Kento Umino; Daisuke Minakata; Hirofumi Nakano; Ryoko Yamasaki; Yasufumi Kawasaki; Miyuki Sugimoto; Masahiro Ashizawa; Chihiro Yamamoto; Kaoru Hatano; Kazuya Sato; Iekuni Oh; Ken Ohmine; Kazuo Muroi; Kentaro Ashizawa; Yu Yamamoto; Hisashi Oshiro; Yoshinobu Kanda
Acta Haematol (2019) 141 (3): 158–163. https://doi.org/10.1159/000492743
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Original Paper

Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis
Subject Area: Hematology , Oncology
Zhichao Li; Yinmei Liu; Qing Wang; Linjun Chen; Liyuan Ma; Siguo Hao
Acta Haematol (2019) 141 (3): 164–175. https://doi.org/10.1159/000495206
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Prognostic Value of Platelet Count in Patients with Peripheral T Cell Lymphoma
Subject Area: Hematology , Oncology
Mihong Choi; Jeong-Ok Lee; Jongheon Jung; Ji Yun Lee; Eunyoung Lee; Hyewon Lee; Soo-Mee Bang; Hyeon Seok Eom; Jong Seok Lee
Acta Haematol (2019) 141 (3): 176–186. https://doi.org/10.1159/000495337
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Editorial Comment

Current Real-Life Results and Future Options of Gemcitabine-Based Salvage Therapy for Relapsed or Refractory Non-Hodgkin Lymphoma
Subject Area: Hematology , Oncology
Antonio Gutierrez
Acta Haematol (2019) 141 (3): 187–188. https://doi.org/10.1159/000496915
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Original Paper

Short-Term Fasting Induces Cell Cycle Arrest in Immature Hematopoietic Cells and Increases the Number of Naïve T Cells in the Bone Marrow of Mice
Subject Area: Hematology , Oncology
Teruhito Takakuwa; Yasuhiro Nakashima; Hideo Koh; Takahiko Nakane; Hirohisa Nakamae; Masayuki Hino
Acta Haematol (2019) 141 (3): 189–198. https://doi.org/10.1159/000496096
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Letter to the Editor

A Novel Association between Antiretroviral Therapy and Drug-Induced Immune Thrombocytopenia Purpura
Subject Area: Hematology , Oncology
Matthew D. Howard; Shirlene Sim
Acta Haematol (2019) 141 (3): 199–200. https://doi.org/10.1159/000496325
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
AI Applications in Transfusion Medicine: Opportunities, Challenges, and Future Directions
Favorable rates of cardiovascular events with stringent cardiovascular monitoring and a lowered dose of ponatinib as second line treatment in chronic phase chronic myeloid leukemia (CML-CP) patients failing or intolerant to first-line second generation tyrosine kinase inhibitor (TKI) treatment: Results of the prospective PONS trial
Dose reduced induction therapy (A)-AIDA in patients with AML, being unfit for standard 7+3 chemotherapy and Literature Review of AML treatment in unfit/older AML patients
Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in Pediatric Acute Lymphoblastic Leukemia
  • Online ISSN 1421-9662
  • Print ISSN 0001-5792
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal